Short Interest in The Andersons, Inc. Rises 30.2%

Insiders sell shares as short bets against the company increase

Mar. 29, 2026 at 7:51am

The Andersons, Inc. (NASDAQ:ANDE) saw a significant 30.2% increase in short interest during March, with 901,156 shares now sold short, representing 2.8% of the company's total shares outstanding. This comes as insiders at the company have been selling their own shares, with several executives and directors reducing their positions.

Why it matters

The rise in short interest suggests some investors are betting against The Andersons, potentially signaling concerns about the company's future performance. Insider selling can also be a bearish indicator, as company insiders often have the best insight into a firm's prospects.

The details

As of March 13th, there were 901,156 shares of The Andersons sold short, up 30.2% from the 692,231 shares that were short as of February 26th. Based on the company's average daily trading volume of 334,436 shares, the current short interest represents 2.7 days' worth of trading.

  • Short interest data is as of March 13, 2026.
  • Short interest increased 30.2% from the February 26, 2026 figure.

The players

The Andersons, Inc.

An Ohio-based diversified agriculture company that operates in grain, ethanol, and other agribusiness segments.

Brian K. Walz

Vice President at The Andersons who sold 8,975 shares on March 12th.

John T. Stout, Jr.

Director at The Andersons who sold 2,500 shares on March 17th.

Got photos? Submit your photos here. ›

What’s next

Investors will be closely watching to see if short interest in The Andersons continues to rise, which could signal growing bearishness about the company's outlook. Additionally, any further insider selling activity will be monitored for signs of management's confidence in the firm's prospects.

The takeaway

The spike in short interest and insider selling at The Andersons suggests some investors and company insiders may be growing more pessimistic about the agriculture firm's future performance, though the overall consensus rating from Wall Street analysts remains a 'Moderate Buy'.